Market open
Longeveron/$LGVN
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About Longeveron
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Ticker
$LGVN
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
25
ISIN
US54303L2034
Website
Longeveron Metrics
BasicAdvanced
$21M
-
-$2.05
-
-
Price and volume
Market cap
$21M
52-week high
$2.24
52-week low
$1.20
Average daily volume
124K
Financial strength
Current ratio
5.608
Quick ratio
5.27
Long term debt to equity
3.87
Total debt to equity
7.547
Management effectiveness
Return on assets (TTM)
-72.08%
Return on equity (TTM)
-167.59%
Valuation
Price to revenue (TTM)
7.878
Price to book
2.38
Price to tangible book (TTM)
2.75
Price to free cash flow (TTM)
-1.058
Growth
Revenue change (TTM)
127.51%
Earnings per share change (TTM)
-78.43%
3-year revenue growth (CAGR)
19.62%
3-year earnings per share growth (CAGR)
-38.53%
What the Analysts think about Longeveron
Analyst Ratings
Majority rating from 2 analysts.
Longeveron News
AllArticlesVideos
Longeveron® Named XPRIZE Healthspan Semifinalist and Top 40 Milestone 1 Award Recipient
GlobeNewsWire·4 days ago
Longeveron Inc. (LGVN) Q1 2025 Earnings Call Transcript
Seeking Alpha·7 days ago
Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update
GlobeNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Longeveron stock?
Longeveron (LGVN) has a market cap of $21M as of May 16, 2025.
What is the P/E ratio for Longeveron stock?
The price to earnings (P/E) ratio for Longeveron (LGVN) stock is 0 as of May 16, 2025.
Does Longeveron stock pay dividends?
No, Longeveron (LGVN) stock does not pay dividends to its shareholders as of May 16, 2025.
When is the next Longeveron dividend payment date?
Longeveron (LGVN) stock does not pay dividends to its shareholders.
What is the beta indicator for Longeveron?
Longeveron (LGVN) does not currently have a Beta indicator.